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Guest Editorial
Our Contribution to the
Public Fear of Cancer
With the bestofintentions, thescientific communityhas managed to
confuse thepublicabout the causes ofcancerand to add to an almost
irrational fear of the disease. The only way to allay this fear is to
develop effective treatment and to understand howcancerdevelops. I
believe that our investment in medical research is finally bringing us
nearbothgoals.
Aformer student ofmine, who nowdeals with toxicwastes as a
public health officer in a state department ofhealth, had a chance to
lecture me recently on the difference between describing the result of
laboratory studies and being closeted in a room with a group of
frightened and angrycitizens wanting to knowwhat was going on in
the area in which they live. It is clear that we as scientists have, over
the years, contributed to the fright; furthermore, the way in which
science operates almost guarantees this effect, especially given a sub-
ject as emotionallycharged as cancer research. We see it as ourjob to
propose hypotheses to explain our data. It is almost a point ofpride
when such hypotheses need to be revised as a result ofthe accumula-
tion ofnew information. We present these hypotheses with as much
vigor as possible, so much so that a report ofan investigation in the
public press, no matter how carefully monitored, is likely to be read
to mean that aclaim or aproposal is afact. The end result is that the
public has been given what seems to be different and inconsistent
advice overthe pastseveralyears.
The advice represented our best information at the time, but it
has never been made clearwhen this information was superseded and
what remains ofvalue. Forexample, manyyears ago, thechairman of
mydepartment told meconfidentially thatwe nowknewthatviruses
were the cause ofcancer. I was in amicrobiology department and his
specialty was virology, but what he said seemed reasonable at the
time, when tumor viruses and oncogenes were just being discovered
(1). Shortly thereafter, it was recognized that (many) carcinogens
were either mutagens or could be activated to produce mutagens (2.
It seemed to followthat, because all carcinogens were mutagens, can-
cer arose as a result ofexternal mutagenic agents. It was, in part, to
address the threat ofthese pollutants that the various environmental
mutagen societies were founded. The idea that all carcinogens were
mutagens waspresented so attractivelythatsome ofmycolleagues are
still astounded to be told that only about a half of all compounds
with carcinogenic activity are genotoxic mutagens (3). Cancer inci-
dence in the general population could be seen as an extension ofthe
documented hazards of the workplace. Media reports of new toxic
nightmares heightened these perceptions, and the "Love Canal"
served as aparadigm for thedecline ofalivableenvironment (4).
It nowseems that the reports ofthe environmental effects ofliv-
ing near Love Canal were overdone (5), just as it also seems likely
that while the conductors of electricity with their accompanying
magnetic fields may be eyesores, they are not demonstrable health
hazards (6,7). A current view is that given a safe workplace, the
remaining risk factors (sunlight, diet, smoking ) are, for the most
part, under our individual control (8). Normally occurring oxidative
processes are seen to damage DNA (9). Inflammation as a response
to infectious agents can be mutagenic (10). Breathing is carcinogenic
although difficult to limit. But this
view of individual responsibility has
been added to, not substituted for, i .
the perceptions of increasing envi-
ronmental hazard.
The public's ability to make i
rational judgments is confounded by
the perception that there are too
many causes of cancer and no (per-
ceived) easy cures. What is the practical meaning ofthe statement
that the production of a malignant tumor does indeed require a
number ofdifferent steps? Furthermore, each of the factors repre-
sents a probability whose importance needs to be individually evalu-
ated. As studies ofthe way families respond to genetic counseling
make clear, judgments based on probabilities are difficult for the
public to make (11,12).
These are problems that are literally impossible to address, given
our present state ofknowledge. The public's responses to discussions
ofcancer are reminiscent ofsocieties responses to the threat of epi-
demics before the nature ofinfectious disease was understood [but
after the demonstration that cholera was related to a particular com-
mon water pump in London (13)]. Just as with infectious disease,
two factors are required to ease the public's anxiety. We need a set of
treatments more rational than the shotgun chemotherapy ofthe pre-
sent, and we need to have some idea about the cause ofcancer. The
national investment in medical research is about to yield major
progress in both these areas. Whether the advance will be the use of
angiostatin (14), DNAvaccines (15), or some other methodology, it
seems that molecular biology, biochemistry, and genetics are about to
present physicians with more practical, more efficacious, and more
humane tools. In addition, evidence is accumulating that there is a
"first event" which sets off the progression characteristic ofcarcino-
genesis and that will be considered the "cause" of cancer.
Furthermore, this initiatingeventwill turn out to be epigenetic rather
than genetic and therefore susceptible to pharmacological manipula-
tion. Ofcourse it is quite dear that specific genetic changes do play a
critical role in carcinogenesis. Inactivation ofa variety ofcontrol sys-
tems must occur to overcome the redundant mechanisms required to
transform a normal cell into a malignant cell. Because so many
changes accumulate, it has been supposed that the first changes pro-
duce a mutator phenotype which then permits the rest to develop
(16). The new evidence also suggests that at least a transitory muta-
genic state is characteristic ofdeveloping tumors (17). Transitory
mutagenic states involving subpopulations ofcells are characteristic of
both stationary bacterial populations and cells involved in generating
antibodydiversity (18,19). Atransitorystate was also suggested many
years ago in cells exposed to small doses of radiation (20). Recent
experiments provide a due as to how such a transitorystate might be
generated. Increased mutation can come from the failure ofthe sur-
veillance mechanisms that correct unfaithful DNA synthesis. Until
recently, itwas supposed thatsuch failure could onlycomeabout as a
result of genetic instability. Now, in a significant number of cases
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[andas Hofliday (21) andotherssuggestedlongago], hypermethylation
of the promoters ofmismatch repair genes can down-modulate the
expression ofgenes whose products minimize cellular mutation (22).
The methylation itselfis experimentally reversible by azacytidine treat-
ment (23). Given a physiological reversal, hypermutabiity could then
appear and disappear without leaving a trace other than the genetic
mutations producedduringthecriticalphase. Thecauseofcancerwould
thenbewhateverepigeneticeventgenerated thisfirsthypermutability.
This is a tremendously hopeful conclusion. First, it provides a
new focus for investigation along a path previously followed by only
the very few adherents ofthe hypothesis that epigenetic events were
important. More importantly, it provides a significant possibility for
intervention at the earliest stages of carcinogenesis as a result of
understanding the nature ofthe epigenetic events involved and the
factors, induding dietary factors, that operate to maintain normal
levels ofmethylation and/or to reverse them.
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